A phase-I study of the combination of intravenous reovirus (REOLYSIN ®) and gemcitabine in patients with advanced cancer

Authors
Category Primary study
JournalEuropean Journal of Cancer, Supplement
Year 2009
This article has no abstract
Epistemonikos ID: 9e2e96f9136af35b8253dd6c20287d26afb074ff
First added on: Mar 01, 2025